Gilead Sciences Inc. shares inched 0.80% higher to $67.18 Thursday, on what proved to be an all-around great trading session for the stock market, with the S&P 500 Index SPX rising 0.58% to 4,266.49 and the Dow Jones Industrial Average DJIA rising 0.95% to 34,196.82.
Gilead Sciences Inc. closed $11.76 below its 52-week high ($78.94), which the company reached on July 20th.The stock demonstrated a mixed performance when compared to some of its competitors Thursday, as Johnson & Johnson JNJ rose 0.46% to $163.37, Merck & Co. Inc. MRK rose 1.03% to $76.36, and AbbVie Inc. ABBV rose 0.65% to $114.74.
Heading into today, shares of the HIV and hepatitis C drugmaker had gained 0.45% over the past month, lagging the Medical sector’s gain of 2.01% and the S&P 500’s gain of 2.17% in that time.GILD will be looking to display strength as it nears its next earnings release. In that report, analysts expect GILD to post earnings of $1.74 per share. This would mark year-over-year growth of 56.76%. Meanwhile, our latest consensus estimate is calling for revenue of $6.15 billion, up 19.57% from the prior-year quarter.